Barton P. Bandy
Known title: President and CEOCIK: 0001773309
Associated companies
Transaction History
| HIND | ▼ Sell | Open Market | 11,674 | $5K | 8/5/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 11,442 | $6K | 7/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 8,610 | $8K | 6/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 2,699 | $3K | 6/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 11,417 | $9K | 5/5/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 11,063 | $13K | 4/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 6,538 | $7K | 2/28/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 8,324 | $10K | 1/31/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 7,150 | $13K | 1/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 13,427 | $25K | 12/2/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 13,505 | $36K | 11/2/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 12,565 | $35K | 10/1/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 294,494 | $851K | 9/10/2021 | View on chart |
| HIND | ▲ Buy | Grant | 960,100 | $0 | 7/22/2021 | View on chart |
| HIND | ▲ Buy | Grant | 225,906 | $0 | 7/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vyome Holdings Gets USPTO Patent Allowance for VT-1908
Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.
Vyome Holdings Gets USPTO Patent Allowance for VT-1908. Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.